PubMed Health⌕ Search

Biomedical subjects

Caroline C Morgan

Publications and source records attributed to Caroline C Morgan.

3 recordsLinked to original sources

A comparison of adaptive allocation rules for group-sequential binary response clinical trials.

In clinical trials to compare two or more treatments with dichotomous responses, group-sequential designs may reduce the total number of patients involved in the trial and response-adaptive designs may result in fewer patients being assigned to the inferior treatments. In this paper, we combine group-sequential and response-adaptive designs, extending recent work on sample size re-estimation in trials to compare two treatments with normally distributed responses, to analogous binary response trials. We consider the use of two parameters of interest in the group-sequential design, the log odds ratio and the simple difference between the probabilities of success. In terms of the adaptive sampling rules, we study two urn models, the drop-the-loser rule and the randomized Pólya urn rule, and compare their properties with those of two sequential maximum likelihood estimation rules, which minimize the expected number of treatment failures. We investigate two ways in which adaptive urn designs can be used in conjunction with group-sequential designs. The first method updates the urn at each interim analysis and the second method continually updates the urn after each patient response, assuming immediate patient responses. Our simulation results show that the group-sequential design, which uses the drop-the-loser rule, applied fully sequentially, is the most effective method for reducing the expected number of treatment failures and the average sample number, whilst still maintaining the nominal error rates, over a range of success probabilities.

Clinical Trials as Topic↗

Sample size re-estimation in group-sequential response-adaptive clinical trials.

In clinical trials where the variances of the response variables are unknown, in accurate estimates of these can affect the type II error rate considerably. More accurate estimates of the variances may be obtained by taking a look at the data available part way through the trial and re-calculating the required sample size based on these new estimates. The main impetus for sample size re-estimation came from a two-stage procedure developed by Stein in 1945 and the literature is now replete with variations on this approach. In this paper, existing sample size re-estimation methods for both fixed sample and sequential clinical trial models will be reviewed. These will then be extended for use in group-sequential response-adaptive designs. In particular, a test for a recently developed group-sequential response-adaptive design, which compares two treatments with immediate normally distributed responses and unknown variances, is presented based on a modified version of Stein's test. The principal modifications involve updating the required sample size at each interim analysis and calculating the test statistic based on the current estimates of the variances. Hence, all the available information is used at each stage. Simulation is used to assess to what extent the updating of the required sample size at each interim analysis in the new test helps to attain the nominal error rates. The test is compared to modified versions of a simple test and a Stein-type group sequential t-test studied in the recent literature. These tests calculate the required sample sizes based on less accurate estimates of the variances. The type I error rate is close to the nominal value and the power is more accurately maintained in the new test.

Clinical Trials as Topic↗

Estimation following group-sequential response-adaptive clinical trials.

A sequential clinical trial model is considered in which two treatments with immediate normally distributed responses are to be compared. The class of one-sided group-sequential tests with response-adaptive sampling developed by Jennison and Turnbull is used to investigate which of the treatments has the larger mean response. The power function for this class of tests is the same as that under nonadaptive sampling, and significant decreases in the inferior treatment number can be achieved with only minor increases in the average total sample number. Two inferential methods are considered following the design. Approximate confidence intervals for the treatment mean difference and the individual means are constructed using the pivotal method of Woodroofe, and an approximation to the bias of the maximum likelihood estimator of the treatment mean difference is studied based on the work of Whitehead. Simulation is used to assess the accuracy of both methods for various stopping boundaries and numbers of interim analyses.

Clinical Trials as Topic↗